Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
Angiogenesis is a well-established target in anti-cancer therapy. Although vascular endothelial growth factor (VEGF)-mediated angiogenesis apparently requires the Rho GTPases Rac1 and Cdc42, the relevant mechanisms are unclear. Here, we determined that activated Rac1/Cdc42 in MCF-7 breast cancer cel...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3672132?pdf=render |
| _version_ | 1818510552803049472 |
|---|---|
| author | Ji Ma Yan Xue Wenchao Liu Caixia Yue Feng Bi Junqing Xu Jian Zhang Yan Li Cuiping Zhong Yan Chen |
| author_facet | Ji Ma Yan Xue Wenchao Liu Caixia Yue Feng Bi Junqing Xu Jian Zhang Yan Li Cuiping Zhong Yan Chen |
| author_sort | Ji Ma |
| collection | DOAJ |
| description | Angiogenesis is a well-established target in anti-cancer therapy. Although vascular endothelial growth factor (VEGF)-mediated angiogenesis apparently requires the Rho GTPases Rac1 and Cdc42, the relevant mechanisms are unclear. Here, we determined that activated Rac1/Cdc42 in MCF-7 breast cancer cells could decrease p53 protein levels and increase VEGF secretion to promote proliferation and tube formation of human umbilical vein endothelial cells (HUVECs). However, these effects are reversed after ubiquitin-proteasome breakage. In exploring potential mechanisms for this relationship, we confirmed that activated Rac1/Cdc42 could enhance p53 protein ubiquitination and weaken p53 protein stability to increase VEGF expression. Furthermore, in a xenograft model using nude mice that stably express active Rac1/Cdc42 protein, active Rac1/Cdc42 decreased p53 levels and increased VEGF expression. Additionally, tumor angiogenesis was inhibited, and p53 protein levels were augmented, by intratumoral injection of the ubiquitin-proteasome inhibitor MG132. Finally in 339 human breast cancer tissues, our analyses indicated that Rac1/Cdc42 expression was related to advanced TNM staging, high proliferation index, ER status, and positive invasive features. In particular, our data suggests that high Rac1/Cdc42 expression is correlated with low wt-p53 and high VEGF expression. We conclude that activated Rac1/Cdc42 is a vascular regulator of tumor angiogenesis and that it may reduce stability of the p53 protein to promote VEGF expression by enhancing p53 protein ubiquitin. |
| first_indexed | 2024-12-10T23:21:31Z |
| format | Article |
| id | doaj.art-f54dc56cb9bc420db67b5ed9729d24b3 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T23:21:31Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f54dc56cb9bc420db67b5ed9729d24b32022-12-22T01:29:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6627510.1371/journal.pone.0066275Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.Ji MaYan XueWenchao LiuCaixia YueFeng BiJunqing XuJian ZhangYan LiCuiping ZhongYan ChenAngiogenesis is a well-established target in anti-cancer therapy. Although vascular endothelial growth factor (VEGF)-mediated angiogenesis apparently requires the Rho GTPases Rac1 and Cdc42, the relevant mechanisms are unclear. Here, we determined that activated Rac1/Cdc42 in MCF-7 breast cancer cells could decrease p53 protein levels and increase VEGF secretion to promote proliferation and tube formation of human umbilical vein endothelial cells (HUVECs). However, these effects are reversed after ubiquitin-proteasome breakage. In exploring potential mechanisms for this relationship, we confirmed that activated Rac1/Cdc42 could enhance p53 protein ubiquitination and weaken p53 protein stability to increase VEGF expression. Furthermore, in a xenograft model using nude mice that stably express active Rac1/Cdc42 protein, active Rac1/Cdc42 decreased p53 levels and increased VEGF expression. Additionally, tumor angiogenesis was inhibited, and p53 protein levels were augmented, by intratumoral injection of the ubiquitin-proteasome inhibitor MG132. Finally in 339 human breast cancer tissues, our analyses indicated that Rac1/Cdc42 expression was related to advanced TNM staging, high proliferation index, ER status, and positive invasive features. In particular, our data suggests that high Rac1/Cdc42 expression is correlated with low wt-p53 and high VEGF expression. We conclude that activated Rac1/Cdc42 is a vascular regulator of tumor angiogenesis and that it may reduce stability of the p53 protein to promote VEGF expression by enhancing p53 protein ubiquitin.http://europepmc.org/articles/PMC3672132?pdf=render |
| spellingShingle | Ji Ma Yan Xue Wenchao Liu Caixia Yue Feng Bi Junqing Xu Jian Zhang Yan Li Cuiping Zhong Yan Chen Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS ONE |
| title | Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. |
| title_full | Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. |
| title_fullStr | Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. |
| title_full_unstemmed | Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. |
| title_short | Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. |
| title_sort | role of activated rac1 cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer |
| url | http://europepmc.org/articles/PMC3672132?pdf=render |
| work_keys_str_mv | AT jima roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT yanxue roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT wenchaoliu roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT caixiayue roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT fengbi roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT junqingxu roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT jianzhang roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT yanli roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT cuipingzhong roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer AT yanchen roleofactivatedrac1cdc42inmediatingendothelialcellproliferationandtumorangiogenesisinbreastcancer |